As per the data collected by the Clinical Proteomic Tumor Analysis Consortium (CPTAC) (http://ualcan.path.uab.edu, accessed on 3 June 2021) for GDH1 expression in CRC patients, apropos of different parameters such as different stages of cancer, stage 3 CRC patients were found to have higher GDH1 expression. The gene discussed is GLUD1; the disease is neoplasm.